A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized Covid19 patients shortens their time to recovery by an additional day
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized Covid-19 patients shortens their time to recovery by an additional day.
All study participants received remdesivir, a Gilead Sciences drug previously shown to reduce the time to recovery, defined as being well enough to leave the hospital, by four days on average. Those who also were given baricitinib recovered one day sooner than those given remdesivir alone, Lilly said.
If that's approved, Lilly will propose that the drug be sold through usual commercial means. Based on current pricing, the government would pay $105 per patient per day, and for people with private insurance, hospitals would pay about $150 per day, Lilly said. What a patient ends up paying out of pocket depends on many factors.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's rheumatoid arthritis drug helps recovery in COVID-19 patientsEli Lilly and Co said on Monday its rheumatoid arthritis drug baricitinib shortened the time taken to recover from COVID-19 in hospitalized patients when taken in combination with Gilead Sciences Inc's antiviral remdesivir.
Read more »
Eli Lilly Arthritis Drug Helped Hospitalized Covid-19 Patients Recover FasterEli Lilly is seeking emergency-use authorization for the arthritis drug Olumiant after a study found it accelerated the recovery of hospitalized Covid-19 patients who were also treated with Gilead’s remdesivir.
Read more »
Anti-maskers ordered to dig graves for COVID-19 victims in IndonesiaPolice say they hope the punishment will deter others from refusing to wear a face covering in public.
Read more »
Anti-inflammatory drug may shorten COVID-19 recovery timeA drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly...
Read more »
When will there be a COVID-19 vaccine and should you trust that it's safe?Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.
Read more »
HHS Officials Altered CDC COVID-19 Reports to Help TrumpTrump-appointed officials have been interfering to protect the president’s deliberately misleading COVID-19 spin.
Read more »